Protocol No
ARCELLX-ACLX-001-DDBCMA
Phase
I
Summary
This project is being done to study the effects of treatment with SPRX001 protein and ARC-T cells for the treatment of relapsed/refractory multiple myeloma.
Objective
Master Protocol for the Phase 1 Study of Cell Therapies in Multiple Myeloma
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov